Technical Data
S0060-26H
Salmonella sp. (A, B, C1, C2, D, E1 & E2 Groups)
Description:
The core antigen bears the O antigen and is attached to lipid A. These three components together form the lipopolysaccharide (LPS), a major component of the outer membrane of Gram-negative bacteria. The LPS is an endotoxin and induces a strong immune response from the host. Its mutation or removal results in the death of the bacterial cell and as such is a prime target for antimicrobial drugs.

Salmonella enterica,causes typhoid fever, paratyphoid fever and foodborne illnesses.

Applications:
Suitable for use in ELISA, Dot Blot and Immunofluorescence. Other applications not tested.

Recommended Dilutions:
Optimal dilutions to be determined by the researcher.

Hybridoma:
Sp2/0 myeloma cells with spleen cells from Balb/c mice.

Recommended Secondary Antibodies:
I1904-06C: IgG, H&L (HRP) (X-Adsorbed) Pab Gt xMo
I1904-06H IgG, H&L (HRP) (X-Adsorbed) Pab Gt xMo
I1904-14C: IgG, Fc (HRP) Pab Gt xMo
I1904-19C: IgG, F(ab’)2 (HRP) Pab Gt xMo

Storage and Stability:
May be stored at 4°C for short-term only. Aliquot to avoid repeated freezing and thawing. Store at -20°C. Aliquots are stable for 12 months. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap.
TypeIsotypeCloneGrade
MabIgG110F416Affinity Purified
SizeStorageShippingSourceHost
200ug-20°CBlue IceMouse
Concentration:
~1mg/ml
Immunogen:
Heat inactivated Salmonella.
Purity:
Purified by Protein G affinity chromatography.
Form
Supplied as a liquid in PBS, pH 7.4, 0.09% sodium azide.
Specificity:
Recognizes the core antigen of Salmonella enterica, serogroups A (S. paratyphi A), B (S. typhimurium), C1 (S. choleraesuis), C2 (S. newport), D (S. enteriditis), E1 (E. anatum) and E2 (S. selandia). It does not cross-react with Escherichia coli 055:B5, E. coli K12 or Klebsiella pneumoniae.
Intended for research use only. Not for use in human, therapeutic, or diagnostic applications.
1. Marinis, J.M. et al. (2011) A Novel Motif in the Crohn's Disease Susceptibility Protein, NOD2, Allows TRAF4 to Down-regulate Innate Immune Responses. J Biol Chem. 286: 1938-50.